0001820505-21-000002.txt : 20210104 0001820505-21-000002.hdr.sgml : 20210104 20210104155123 ACCESSION NUMBER: 0001820505-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20210104 DATE AS OF CHANGE: 20210104 EFFECTIVENESS DATE: 20210104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Redmile Biopharma Investments III, L.P. CENTRAL INDEX KEY: 0001838746 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-385117 FILM NUMBER: 21501703 BUSINESS ADDRESS: STREET 1: LETTERMAN DIGITAL ARTS CENTER STREET 2: ONE LETTERMAN DRIVE, SUITE D3-300 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 BUSINESS PHONE: 415-489-9980 MAIL ADDRESS: STREET 1: LETTERMAN DIGITAL ARTS CENTER STREET 2: ONE LETTERMAN DRIVE, SUITE D3-300 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 D 1 primary_doc.xml X0708 D LIVE 0001838746 Redmile Biopharma Investments III, L.P. Letterman Digital Arts Center One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 415-489-9980 DELAWARE None None Limited Partnership true 2020 n/a Redmile Biopharma Investments III (GP), LLC Letterman Digital Arts Center One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 Promoter General Partner n/a Redmile Group, LLC Letterman Digital Arts Center One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 Executive Officer Management Company Jeremy Green Redmile Group, LLC One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 Executive Officer Mike Lee Redmile Group, LLC One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 Executive Officer Amrit Nagpal Redmile Group, LLC One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 Executive Officer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 false 2020-12-23 true true false 100000 J.P. Morgan Securities LLC 79 None None 383 Madison Avenue New York NY NEW YORK 10179 All States false Indefinite 500235000 Indefinite false 77 0 0 0 false Redmile Biopharma Investments III, L.P. Rachel Chang Rachel Chang General Counsel of the Management Company 2021-01-04